Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELUMETINIB vs SENNOSIDES: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SELUMETINIB vs SENNOSIDES: Safety Overview

Metric SELUMETINIB SENNOSIDES
Total FAERS Reports 1,172 2,288
Deaths Reported 81 323
Death Rate 6.9% 14.1%
Hospitalizations 211 833
Average Patient Age 25.6 yrs 60.7 yrs
% Female Patients 51.6% 77.0%
FDA Approval Date Apr 10, 2020 N/A
Manufacturer AstraZeneca Pharmaceuticals LP Bryant Ranch Prepack
Route ORAL ORAL
Marketing Status Prescription N/A